Cells within the ventral medulla whose axons descend to the spinal dorsal horn via the dorsolateral funiculus (DLF) play an important role in pain modulation.
The integrity of descending axons within the spinal dorsolateral funiculus (DLF) has proved essential for the expression of analgesia elicited by a variety of methods. It is widely accepted that the specific population of DLF fibers critical for analgesia is derived from serotonergic neurons located in the ventromedial medulla. In theory, activation of this serotonergic bulbospinal pathway inhibits neural input from tissue-damaging stimuli at the spinal level. Support for this model stems from two lines of evidence. The first suggests that analgesia is attenuated by pharmacologic interference with spinal serotonin (5HT) function, while analgesia results from and is accompanied by increases in spinal 5-HT activity. The second provides clear evidence that the DLF is critical for analgesia, while suggesting that the origins of the DLF in the ventral medulla (an area involved in the mediation of antinociception) are largely serotonergic. Accumulating behavioral, biochemical, electrophysiological, and anatomical results provide circumstantial evidence that bulbospinal 5-HT pathways mediate analgesia. Behavioral evidence indicating a physiological role for descending 5HT pathways in mediating morphine analgesia was first provided by Vogt (1973 gesic responses of rats to low systemic doses of morphine. Subsequently, intrathecal injections of putative 5-HT receptor blockers have been shown to attenuate analgesia elicited by morphine injected into the periaqueductal gray (PAG) (Yaksh, 1979) . Conversely, intrathecal injections of high doses of 5-HT cause an increase in tail flick latency (Wang, 1977) . Biochemical data correlate with the behavioral results: increases in spinal 5-HT turnover are observed in response to systemic opiates and electrical stimulation of the ventromedial medulla (Shiomi et al., 1978; Bourgoin et al., 1980 )-manipulations which result in analgesia. Engberg et al. (1968) provided the first electrophysiological evidence for an inhibitory serotonergic pathway from the medulla to the spinal cord. They observed a slight attenuation of the tonic inhibition exerted by the medulla on spinal cord cells following the systemic administration of putative 5-HT receptor blockers. Subsequently, iontophoretic applications of 5-HT to sensory neurons in the spinal cord have been shown to depress their responses to noxious peripheral stimuli (Randic and Yu, 1976; Belcher et al., 1978; Headley et al., 1978; Jordan et al., 1978) . However, depression of tonic firing rates may also result from 5-HT applications (Belcher et al., 1978) . Finally, anatomical studies have identified an extensive network of 5-HT terminals in the dorsal horn (Ruda and Gobel, 1980) , an area which participates in the modulation of ascending sensory information.
There is convincing evidence that both analgesia and the electrophysiological sequelae resulting from manipulations which produce analgesia require the integrity of the DLF. Behavioral experiments have shown that le- Vol. 4, No. 3, Mar. 1984 sions of the DLF will block analgesia induced by electrical stimulation of the PAG (Basbaum et al., 1977) , systemic morphine (Basbaum et al., 1977; Rydenhag and Andersson, 1981) , microinjection of morphine into the PAG (Murfin et al., 1976) , and various environmental manipulations . Electrophysiological studies have demonstrated the essential role of the DLF in maintaining the tonic inhibition of flexion reflexes seen in the decerebrate state (Holmqvist and Lundberg, 1959) . This inhibition is mimicked by direct electrical stimulation of the DLF (Holmqvist and Lundberg, 1959) . The attenuation of dorsal horn cells' responses to noxious stimuli resulting from stimulation of the ventromedial medulla is also dependent on the DLF (Fields et al., 1977; Willis et al., 1977) . Identification of the supraspinal origins of the DLF has revealed a large contribution from cells of the ventral medulla (Basbaum and Fields, 1979; Watkins et al., 1980) , specifically nucleus raphe magnus and the ventral portions of the nucleus reticularis gigantocellularis: areas from which analgesia can be elicited by electrical or chemical stimulation (Akaike et al., 1978; Dickenson et al., 1979; Oliveras et al., 1975; Satoh et al., 1980) . The proximity of these cells to the serotonergic cell group B3 has led to the proposal that these medullary cells at the origin of the DLF are serotonergic (Watkins et al., 1980) . A pathway originating in the nucleus raphe magnus, descending via the DLF, and terminating in the spinal dorsal horn has been described (Basbaum et al., 1976) .
Recently, however, the use of direct applications of monoaminergic neurotoxins to the spinal cord has demonstrated that spinal 5-HT is not necessary for analgesia produced by some methods. Analgesia produced by stimulation of, or morphine microinjection into, the PAG (Johannessen et al., 1982) or by systemic morphine (Proudfit and Yaksh, 1980 ) is unaffected by spinal 5-HT depletion. Furthermore, the original study of Vogt (1973) , often cited as evidence for the serotonergic mediation of descending inhibition, reported the effects of spinal 5-HT depletion on morphine analgesia to be "mild" as compared to a manipulation which depleted both spinal and medullary 5-HT. Electrophysiological evidence indicates that the inhibition of spinal nociceptive responses by medullary stimulation is, at best, minimally affected by 5HT blockers (Griersmith et al., 1981; Yezierski et al., 1982) . Recent studies have found the tonic descending inhibition of dorsal horn cells to be completely unaffected by the administration of a 5-HT synthesis inhibitor (Soja and Sinclair, 1980) or by putative 5-HT antagonists (Griersmith et al., 1981) . There are, then, lines of direct evidence which indicate that spinal 5-HT is not necessary for the production of analgesia.
In light of the functional significance currently placed on inhibitory bulbospinal 5-HT pathways within the DLF, we thought it important to examine whether the medullary cells which descend via the DLF are, in fact, serotonergic. The recently reported double labeling technique (Bowker et al., 1981b) , which allows simultaneous visualization of retrogradely transported horseradish peroxidase (HRP) and serotonin-like immunoreactivity (SLI), has enabled us to address this question directly.
Retrograde labeling from the cervical DLF was chosen for several reasons. First, the pattern of medullary cells retrogradely labeled from various spinal levels remains constant, but the number of cells labeled from cervical implants is greater (Watkins et al., 1980) , maximizing the chances of seeing double-labeled cells. Second, Rydenhag and Andersson (1981) have shown that all DLF lesions made above spinal segment T9 are effective in blocking morphine analgesia. Thus the descending inhibitory pathways activated by morphine remain within the DLF until T9. Finally, the question being addressed has as much functional relevance as anatomical relevance. As such, the fact that cervical DLF lesions are effective in blocking analgesia induced by a variety of methods (Rydenhag and Andersson, 1981; Watkins and Mayer, 1982) is sufficient justification for restricting the HRP implants to the cervical level.
Materials and Methods
Experimental design. Two approaches were used to test whether the medullary origins of the DLF in the rat are serotonergic. In most cases, unilateral retrograde labeling with HRP from one cervical DLF (C4-5) was combined with 5-HT immunohistochemistry. To confirm the efficacy of the double labeling technique, double staining was carried out after large HRP injections into the cord. Additionally, double labeling of 5-HT cells was attempted using large spinal HRP injections in animals in which one or both DLFs were cut rostra1 to the injection site.
Retrograde Labeling. Discrete retrograde labeling from the DLF was accomplished by the method of Griffin et al. (1979) . Solid HRP was incorporated into 0.2 ml of a 15% polyacrylamide gel (Bio-Rad). A minute piece of HRP gel was cut, allowed to dry, and surgically implanted into a small unilateral incision of the cervical DLF (C4-5). To achieve more diffuse retrograde labeling from the cord, a 20% (w/v in saline) liquid HRP solution was used. Multiple injections totaling 10 ~1 were made through a 33 gauge needle over a l-cm segment of lumbar cord. All results, unless otherwise noted, represent a 2-day survival after HRP administration.
Histological procedures. Rats were treated with 25 mg/ kg of Nembutal (sodium pentobarbital) given subcutaneously, 100 mg/kg of L-tryptophan (Sigma) dissolved in saline and injected intraperitoneally, and 50 mg/kg of pargyline hydrochloride (Sigma) injected intraperitoneally. Two hours later animals were dosed with barbiturate (70 mg/kg) and perfused transcardially with 500 ml of heparinized saline followed by 500 ml of cold paraformaldehyde (3.5 to 4%) in phosphate-buffered saline (PBS), pH 7.4. The brains and spinal cords were immediately removed and placed in cold 10% sucrose in PBS, where they remained overnight until sectioning.
Double retrograde/5-HT staining was carried out according to the method of Bowker et al. (1981a) . Frozen sections (30 pm) of the medulla were collected in cold PBS. For retrograde staining, free floating sections were incubated at room temperature through the following series of solutions: 0.1 M Tris buffer, pH 7.4, 10 min; 0.5% CoCIZ in 0.1 M Tris, pH 7.4, 10 min; 0.1 M Tris, pH 7.4, 10 min; PBS, pH 7.4, 10 min; and 3,3'-diaminobenzidine hydrochloride (DAB, Sigma), 25 mg/lOO ml in PBS, pH 7.6, 10 min. A solution of HzOz (0.5 ml of 3% Hz02/100 ml) was added to the DAB solution and incu-bation was continued for an additional 15 min. Two final washes in PBS preceded the 5-HT staining. Sections of the spinal HRP-gel implant site were collected into PBS, then reacted with benzidine dihydrochloride (BDHC) (Mesulam, 1976) .
To visualize the SLI cells, free floating sections were incubated in refrigerated antiserum to 5HT (donated by Dr. Robert Elde). Dilutions ranging from 1:2000 to 1:4000 were made in PBS (pH 7.4) containing 1% normal goat serum (Antibodies, Inc.). After 2 days, sections were washed overnight in cold PBS. Subsequent incubations, all at room temperature, were as follows: goat anti-rabbit IgG (Antibodies, Inc.) 1:150 in PBS, 3 hr; PBS wash twice for 1 hr; and rabbit peroxidase-antiperoxidase (Sternberger-Meyer) 1:80,3 hr; PBS wash twice for 1 hr. The peroxidase was reacted in a solution of DAB (15 mg/IOO ml in Tris, pH 7.5, containing 0.5 ml of 3% H,O,). The optimum incubation time was determined empirically for each tissue batch by reacting a few sections for times ranging from 2 to 20 min and immediately mounting and viewing these sections before developing the remaining sections. The tissue was then washed in PBS and mounted from 1.5% alcoholic gelatin onto slides. After air drying, the sections were dehydrated through a graded series of alcohols, cleared in xylene and coverslipped.
In some cases, alternate medullary sections were developed for retrograde HRP only using BDHC, so that the efficacy of the DAB-CoCl* retrograde staining could be monitored. The distribution of retrogradely labeled cells visualized by the two methods could thus be compared.
Results Cells in the ventral medulla which labeled from the cervical DLF were found to be almost exclusively nonserotonergic. At the level which includes the facial nucleus and nucleus raphe magnus no more than two double-labeled cells were ever seen in a single section. Unilateral retrograde labeling from the DLF combined with 5-HT immunohistochemistry produced the staining pattern seen in Figure 1A . Laterally, cells giving rise to the DLF lie dorsal to cells exhibiting SLI (Fig. lB) , while an intermingling of the two cell types is seen medially (Fig.  1C) . Figure 2A provides a rostrocaudal profile of cells labeled from the DLF, SLI cells, and double-labeled cells. At the level of the inferior olive, SLI cells were found either along the midline in nucleus raphe pallidus (Bl) and nucleus raphe obscurus (B2), or at the extreme ventrolateral border of the medulla (nucleus interfascicularis hypoglossi). Cells projecting down the DLF were found in a band between these two serotonergic cell groups, extending from the dorsal accessory nucleus of the inferior olive into the nucleus reticularis pars ventralis or, at more rostra1 olivary levels, the nucleus reticularis gigantocellularis.
An occasional double-labeled cell was seen at the lateral edge of nucleus raphe obscurus or just above the inferior olive.
Approaching the rostra1 pole of the inferior olive, SLI cells form an unbroken band which extends from the midline to the ventrolateral border of the medulla. At this same level, SLI cells within nucleus raphe obscurus become less numerous. The effect is a gradual disappearance of nucleus raphe obscurus and simultaneous fusion of the medial and lateral groups in successively more rostra1 sections. Cells labeled from the DLF appear with increasing frequency near the midline and, with the disappearance of the inferior olive, form a horizontally oriented band extending from the midline laterally over the pyramids.
The most extensive group of cells labeled from the DLF occurs at the level of nucleus raphe magnus and the facial nucleus. At this level these cells form an arched band which extends from the midline, up over the pyramids to the medial edge of the facial nucleus. On the midline, cells are found within the nucleus raphe magnus where their ventralmost extent is the nucleus raphe pallidus. More laterally, however, the cells follow an arched line extending from the pyramids ventrally, well into the nucleus reticularis gigantocellularis.
This entire band of DLF projecting cells has been termed the nucleus raphe alatus ). It appears to form a functional unit (Zorman et al., 1981) . At this same level, SLI cells were found in the nucleus raphe magnus medially, intermingled with DLF projecting cells. More laterally, SLI cells occupy a generally more ventral position, lying between the cells of nucleus raphe alatus and the pyramids. A few SLI cells were seen within the pyramids or on their ventral border. An occasional double-labeled cell was seen either medially or at the dorsoventral border between the lateral parts of B3 and nucleus raphe alatus.
At the level including the genu of the VIIth nerve and the trapezoid body, there is an intermingling of SLI and retrogradely labeled cells within the rostra1 nucleus raphe magnus. Retrogradely labeled cells tend to be concentrated near the midline, whereas serotonergic cells extend laterally over the trapezoid body. In summary, virtually all cells retrogradely labeled from the DLF were nonserotonergic.
Results using injections of HRP solutions. Large liquid injections of an HRP solution (20% w/v, 10 ~1) into the lumbar cord resulted in extensive double labeling of all of the 5-HT cell groups of the lower medulla. As shown in Figure 2B , extensive retrograde labeling of the reticular core was achieved. In a typical section at the level of the facial nucleus, 75% of the serotonergic neurons were double labeled. Thus, the results of Bowker et al. (1981a) have been confirmed, and we have demonstrated the validity of the double-staining procedure in our laboratory.
Combining lumbar HRP injections with unilateral or bilateral cervical lesions of the DLF provided two important results. First, DLF lesions failed to eliminate retrograde labeling in histochemically identified serotonergic neurons in the ventral medulla. As seen in Figure 3 , double-labeled cells are seen both medially in nucleus raphe magnus (Fig. 3A) and laterally (Fig. 3B) . Thus axons from these neurons can reach the spinal cord by routes other than the DLF. Second, we found a considerable overlap in the distribution of DLF projecting and non-DLF projecting bulbospinal neurons. This heterogeneity is further complicated by the extensive mixture of neurochemically distinct cell types. These findings are illustrated in Figure 4 .
Internal controls. The validity of these results is, of Figure 1 . A, Photomicrograph of the rat ventral medulla at the level of the nucleus raphe magnus illustrating the pattern of staining resulting from a unilateral placement of HRP in the left cervical DLF combined with 5HT immunohistochemistry. A large group of DLF projecting ceils can clearly be seen lying dorsal to 5-HT cells on the left. This section is taken from the case drawn in Figure 2A course, dependent on the specificity of the SLI staining and the completeness of the retrograde staining from the DLF. The distribution of SLI cells corresponded to the pattern of histofluorescent cells described by Dahlstrom and Fuxe (1964) and with the previous description of SLI cells by Steinbusch (1981) . The staining intensity was reduced in rats not pretreated with L-tryptophan and pargyline. Additionally, the substitution of rabbit primary antisera directed against other antigens (e.g., pendorphin) yielded a completely different pattern of staining. These results strongly suggest the staining is specific for 5-HT-containing neurons.
The possibility that 5-HT immunoreactivity obscured weak retrograde staining, or that the CoC12-DAB method was insensitive and failed to detect a significant number of retrogradely labeled cells, was examined by staining alternate sections with BDHC, a more sensitive HRP method, and comparing the distributions of cells. The DAB-CoC12 retrograde staining did provide variable results. Some double-labeled material was nearly devoid of retrograde staining, whereas other cases provided retrograde labeling equivalent to that seen with BDHC. The data presented are from these latter cases.
In summary, we find that cells at the origin of the cervical DLF in the ventral medulla are predominantly non-serotonergic. This result has been confirmed by two approaches: by the absence of a significant number of double-labeled cells after discrete retrograde labeling from the DLF, and by the persistence of double-labeled 5-HT cells after surgical lesions of one or both DLFs. Furthermore, DLF projecting cells, serotonergic non-DLF projecting cells, and non-serotonergic, non-DLF projecting cells were found to intermingle extensively in the nucleus raphe magnus indicating an extensive heterogeneity within this area.
Discussion
Our results provide the first direct evidence that the vast majority of cells within nucleus raphe magnus and nucleus reticularis gigantocellularis which descend via the DLF are non-serotonergic. The existence of this large non-serotonergic bulbospinal pathway within the DLF is supported by previous behavioral, physiological, and anatomical results.
Functional activity in this raphe-spinal pathway a measured by behavioral and physiological methods suggests a non-serotonergic component. Behaviorally, potent analgesia can be elicited in both the cat (Oliveras et al., 1975) and the rat (Zorman et al., 1981) by electrical stimulation of the ventral medulla. In both cases the analgesia can be blocked by naloxone. In the rat this blockade also results if the naloxone is restricted to the spinal cord, indicating that a spinal opioid synapse mediates the analgesia. Therefore, if analgesia resulting from stimulation of the ventral medulla results solely from descending serotonergic terminals activating intrinsic spinal opioid interneurons, then analgesia elicited by intrathecal5-HT should be naloxone reversible. It is not (Yaksh and Wilson, 1979) . Two other forms of analgesia are mediated by spinal opiates : analgesia resulting from brief acute shock applied to the forelimbs, and a classically conditioned form of analgesia which results from exposure to a non-electrified grid following three daily periods of shock. Both forms of analgesia are blocked by lesions of the ventral medulla or the DLF, and by intrathecal naloxone. While analgesia induced by acute shock is attenuated by spinal 5-HT depletion, classically conditioned analgesia is not (Watkins et al., 1984) . At the physiological level, the increased activity of certain raphe-spinal cells in response to noxious peripheral stimulation and to systemic morphine (Anderson et al., 1977) is strongly indicative of their participation in bulbospinal inhibition. However, within the cat nucleus raphe magnus the vast majority of cells exhibit conduction velocities much higher than those characteristic of serotonergic neurons (West and Wolstencroft, 1977) . This paucity of slowly conducting cells is seen even when the sample population is restricted to DLF projecting cells which respond to noxious stimuli (Anderson et al., 1977) . In addition, the inhibition of second-order nociceptive neurons by medullary raphe stimulation is only minimally affected by serotonin antagonists (Griersmith et al., 1981; Yezierski et al., 1982) . Thus, behavioral and physiological evidence indicate the importance of non-serotonergic pathways within the DLF in the production of analgesia. Other anatomical evidence is consistent with our conclusion that the ventral medulla-DLF pathway is nonserotonergic. Injections of tritiated amino acids into the cat nucleus raphe magnus reveal a heavy projection which descends via the DLF to terminate in the dorsal horn-specifically in the marginal zone, substantia gelatinosa, and laminae V (Basbaum et al., 1976; Holstege and Kuypers, 1982) . Several facts suggest that this pathway is predominantly non-serotonergic. First, Wiklund et al. (1981) have found that serotonergic neurons comprise only a minor portion of the cells in the nucleus raphe magnus. Second, Holstege and Kuypers (1982) have demonstrated the same DLF projection and spinal terminal distribution following injections into lateral areas which are devoid of serotonergic cells. Third, the pattern of serotonergic terminals seen in the dorsal horn does not match the laminar pattern of terminals originating in nucleus raphe magnus. Whereas serotonergic staining in the superficial layer of the dorsal horn is heavy, the remainder of the dorsal horn shows a more uniform fiber density . In addition, Nishikawa et al. (1982) have provided direct evidence that serotonergic terminals are not found exclusively on nociceptive second-order neurons, but are also found in abundance on lamina IV cells which project via the dorsal columns to the dorsal column nuclei. In total these facts suggest that the bulbospinal pathway originating in nucleus raphe magnus described by Basbaum et al. (1976) and by Holstege and Kuypers (1982) is predominantly non-serotonergic.
In addition to our main conclusion of a non-serotonergic predominance in the bulbospinal-DLF pathway, our data imply that only a small fraction of 5-HTcontaining cells in the ventral medulla descend to the Figure 5 . Sagittal view of the rat cervical spinal cord stained for SLI. Whereas the ventral horn (C) exhibits a random 5-HT fiber pattern, 5-HT fibers in the dorsal cord (23) are arranged in a rostrocaudal direction. Long single axons can be followed within a section for considerable distances (arrows), suggesting the possibility that some serotonergic fibers descend to the cord exclusively within the dorsal horn. VH, ventral horn; DH, dorsal horn; the intervening white matter is the lateral funiculus.
cord via the DLF. Both Dahlstrom and Fuxe (1965) and Steinbusch (1981) have noted 5-HT-containing fibers in the spinal white matter, primarily in ventral areas but also within the DLF. Since we have not attempted a quantitative approach, it is unclear whether the small number of serotonin-containing cells labeled from the DLF is sufficient to account for these observations. However, several possibilities emerge for alternate routes for descending serotonergic fibers. First, Dahlstrom and Fuxe (1965) show 5-HT-containing fibers entering the dorsal horn from the ventral, intermediate and dorsal aspects of the lateral funiculus, suggesting a diffuse route of descent. Second, SLI fibers have been described within the dorsal columns (Hancock, 1982) . As yet the origin of these fibers is unknown. A third possibility emerges from a close examination of the arrangement of 5-HT fibers in the spinal cord. When viewed in the sagittal plane, serotonergic fiber patterns differ greatly between the dorsal and ventral horn (Fig. 5) . Ventral horn fibers are randomly oriented (Fig. 5C ), and fibers can be seen entering and leaving the gray matter. On the other hand, fibers in the dorsal horn adhere to a distinct rostrocaudal orientation. Single fibers can be followed for considerable distances (Fig. 5B ) and are rarely seen entering or leaving the gray matter. This strongly suggests that some serotonergic fibers descend entirely within the confines of the dorsal horn, influencing large segments of spinal cord by virtue of numerous boutons of passage. The fact that cells within the ventral medulla innervate multiple cord levels (Huisman et al., 1981) is consistent with this hypothesis.
Serotonergic fibers lying outside the DLF do appear to have a functional role in the production of analgesia. While the argument has been made here that behavioral, physiological, and anatomical evidence indicate that the notion of a bulbospinal serotonergic system acting as a final common pathway for all forms of analgesia is clearly incorrect, there is evidence that spinal 5-HT depletion does attenuate some forms of endogenously mediated analgesia (Watkins et al., 1983) . Similarly, descending noradrenergic pathways which are implicated in analgesia (Kuraishi et al., 1979; Reddy and Yaksh, 1980 ) also lie outside the DLF (Kaufman et al., 1983) . It is important to note that, although DLF lesions attenuate analgesia elicited by systemic morphine and manipulations of the PAG, with the exception of electrophysiological paradigms the effects of DLF lesions on analgesia elicited from the ventral medulla are as yet untested.
Behavioral evidence indicates that analgesia may result from simultaneous activation of pathways inside and outside the DLF. As previously mentioned the acute and conditioned forms of footshock-induced analgesia are similar in that they are both blocked by DLF lesions or by intrathecal naloxone, but only the acute form is also attenuated by spinal 5-HT depletion. Since our data indicate that this serotonergic pathway lies outside the DLF, coactivation of two pathways is necessary for this form of analgesia. Furthermore, since the conditioned analgesia is unaffected by spinal 5-HT depletion, elements within the DLF other than those involved in the acute form of the analgesia must be involved-elements which do not require simultaneous serotonergic activation to exert their inhibitory action at the spinal level.
In conclusion, the emerging picture of bulbospinal pathways which inhibit the ascending flow of information about noxious stimuli is complex. There is evidence for multiple pathways which vary in their neurochemical nature and in their route of descent. Analgesia may result from the activation of one or a combination of these pathways. We have shown that the origins of these pathways often do not form discrete nuclei but are comprised of diffuse groups of cells which often intermingle. In light of these facts, new strategies will be required to dissect out the contributions these various cell groups make to the production of analgesia.
References
Akaike, A., T. Shibata, M. Satoh, and H. Takagi (1978) 
